Fair Market ValueMC very likely has not exercised his options with a strike price of $1.45
If he did this on December 13th, then he would have five days to report the transaction. Techincally he could have till mid-week next week to report, but there would be no reason to wait and it would almost certainly have been reported by now had it actually occured.
This is important to note for all current and prospective shareholders of ONC.
Matt Coffey, the CEO of Oncolytics Biotech has let everyone know that by his own analysis, the current fair market value of ONC is less than $1.45 CDN. He's also strongly suggesting by his lack of action that the potential for any major postive news in the next one to two years is exceptionally low.
I'll update this if I see anything different on SEDI, but why the hell anyone would buy at a price over $1.45 when ONC's own CEO refuses the option to buy at $1.45 is beyond me.
A CEO who for all intents and purposes refuses to own more than a token stake in his company is a useless twit in my opinion.